Less medication switching after initial start with atypical antipsychotics

By Hugenholtz G.W.K.   Heerdink E.R.   Nolen W.A.   Egberts A.C.G.  

European Neuropsychopharmacology, Vol. 14, Iss. 1, 2004-01 ,pp. : 1-5

Elsevier

Access to resources Recommend Favorite

Fatalities Associated with Therapeutic Use and Overdose of Atypical Antipsychotics

By Trenton A.J.  

CNS Drugs, Vol. 17, Iss. 5, 2003-01 ,pp. : 307-324

Adis International

Access to resources Recommend Favorite

Treatment-emergent adverse events associated with atypical antipsychotics

By Cha Danielle S   McIntyre Roger S  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 11, 2012-08 ,pp. : 1587-1598

Informa Healthcare

Access to resources Recommend Favorite

Consider the advantages/disadvantages of different switching methods when changing atypical antipsychotics

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 12, 2005-12 ,pp. : 20-23

Adis International

Access to resources Recommend Favorite

Adverse Metabolic Effects Associated with Atypical Antipsychotics: Literature Review and Clinical Implications

By Melkersson K.  

Drugs, Vol. 64, Iss. 7, 2004-01 ,pp. : 701-723

Adis International

Access to resources Recommend Favorite